Health Archive » July, 2011

Health - July, 2011

204 articles

• Covidien Can't Evacuate FLSA Collective Action: Judge
• Fed. Circ. Affirms Lilly's Strattera Patent
• Judge Merges Shareholder Suits Over J&J FCPA Cases
• Fed. Circ. Rules Myriad Can Patent Breast Cancer Genes
• Pfizer Denied New Trial In $200M Neurontin MDL
• Allergan Hit With Off-Label Marketing FCA Suit
• FDA Should Scrap Moderate-Risk Review Process: Report
• Edwards Angell Reps Allied In $175M Sale To Saga
• J&J Cuts Maximum Tylenol Dose to Prevent Liver Damage
• Pfizer Hits Hetero With Suit Over Generic Viagra
• Pfizer, Others Not Liable For Gambling Addiction: 8th Circ.
• Pfizer Units Escape Suit Over Hormone Treatments
• Sen. Threatens To Hold Up FDA User Fee Renewal
• The Proper Care And Feeding Of Experts
• FDA Clarifies When Medical Device Changes Need Approval
• Ex-Taro Exec In Contempt Over $2M Insider Trading Fine
• HHS Lacks Tools To Fight Medicare Waste: Officials
• Ex-Hospital Admins Face 2 Trials In Kickbacks Case
• Health Co. Sued Over Fraud Says US Destroyed Evidence
• Building Your Own Business Development Plan
• AstraZeneca Settles Bulk Of Seroquel Diabetes Claims
• Medtronic Escapes Fraud Claims In Whistleblower Suit
• Judge Won't Bar Federal Funding For Stem Cell Research
• Fed. Circ. Won't Block Watson's Seasonique Generic
• Health Care Reform Opponents Appeal To Supreme Court
• Nelson Mullins Snags Pharma IP Expert
• Pfizer, Apotex To End Fight Over Generic Relpax
• AstraZeneca, Pozen Sue Lupin To Block Generic Vimovo
• Not Enough Evidence Of 9/11, Cancer Link: Report
• ERX Incentive Program Changes — Too Little, Too Late?
• J&J Seeks Fed. Circ. Rehearing On Stent Patents
• Parsing Patent Term Extension In Europe
• Perrigo, Paddock Must Sell 6 Drugs In $540M Merger
• US Airs Disgraced Pol's Calls In Hospital Bribe Trial
• Pharma Cos. Fight Lilly Deposition Bid In Gemzar ITC Case
• Tribal Group Asks High Court To Decide Hospital Row
• Nurses Registry Says Facebook Posts Should Kill FCA Suit
• DaVita Bilked Government For Wasted Kidney Drugs: Suit
• Astellas Stress Test Antitrust Suit Survives
• Trends In Qui Tam False Claims Cases
• Use A Mediator, Get Disbarred
• Medco Investors Fight $29B Sale To Express Scripts
• NexIdea Sues Med-Lift Over Lift Chairs
• CVS Pharmacists Denied Class Cert. In OT Action
• Judge Tosses Boehringer Workers' Wage-And-Hour Suit
• CDER Report Adds To New FDA Research Agenda
• Lupin, Medicis Reach Deal Over Generic Solodyn
• Obama Lays Out New Offensive Against Overseas Cartels
• Allos Investor Tries To Block $686M AMAG Merger
• Ky. Sues McKesson, First DataBank Over AWP Inflation
• Medical Transporter Irving Settles Drivers' FLSA Action
• Bayer One-A-Day False Ad Action Scrapped
• Actos Needs Stronger Cancer Warnings: EU Regulator
• Synthes Targets Globus Over Spine Implant Patents
• 9th Circ. Shuts Down Calif. Inmate Care Antitrust Suit
• Covington Reps Bristol-Myers In $325M Amira Buy
• 1st Circ. Revives FCA Claims In Amgen Kickback Suit
• $10M Suit Says Pfizer Failed To Warn Of Dilantin Effects
• Abbott Hits Hospira With Patent Suit Over Zemplar
• FDA, EU Review Sanofi Heart Drug After Failed Trial
• InformedRx Sued Over Glucose Strip Expiration Dates
• Stiefel ERISA Plaintiffs Lose Class Cert. Bid
• Using The Anti-Injunction Act In Class Actions
• J&J Says Board Not To Blame For Recalls, Corruption Claims
• Bristol-Myers Settles AWP MDL Claims For $19M
• Bayer WeightSmart Buyers Fail To Win Cert. In Ad Suit
• Judge OKs Expired Patents Label In Cold-Eeze Suit
• FTC Says Cardinal Health Must Sell Pharmacies
• Fed. Circ. Says Teva Can't Block Cenestin Generic
• Novartis, Teva End Long-Running Lotrel Patent Suit
• Ropes & Gray Opens Shanghai Office
• Medicis Seeks To Block Generic Loprox Shampoo
• Express Scripts' $29B Medco Buy To Face Antitrust Test
• Pay-For-Delay Ban Heads To Full Senate
• FDA Says Medical Device Reviews Must Be Streamlined
• Caritas Workers' OT Action Doesn't Satisfy FLSA: Judge
• Knobbe Martens Snags IP Atty For Silicon Valley Office
• Cooley, Latham Handle $686M AMAG-Allos Merger
• Using Consent Orders In Mass Tort Litigation
• Merck Fails To Nix Femina Birth Control Patent In ITC Row
• Ex-ArthroCare Exec Mostly Ducks $2.1M SEC Judgment
• Judge Tosses Deceptive Practices Claim In Seroquel Suit
• Zicam Inventor Admits Selling Unapproved Bird Flu Drug
• Aventis, Sun Settle Pair Of Allegra Generic Suits
• Energex CEO Blasted With $9.5M Fraud Suit
• 21 States Back Challenge Of Health Care Law In 8th Circ.
• HGS Patent Suits Against Genentech Head To Calif.
• Kaiser Workers Should Redo Calif. Union Vote: Judge
• Improving The MSP Recovery Process
• False Marking Law Found Constitutional Again
• Lilly Again Sues APP Over Generic Alimta
• US Ends Prezista IP Suit Against Hetero Unit
• Medical Group Defends Ethics Of Egg Donor Price Cap
• PBGC Backs St. Vincent's Auction With Reservations
• Davis Polk Advises Aetna On $202M PayFlex Buy
• Hologic Triumphs In Mammogram Cushion IP Suit
• Suit Blames Diabetes Drug Byetta For Injuries, Deaths
• In Pursuit Of Individual Exclusions
• Amgen, Teva Settle Patent Suit Over Neopogen Generic
• EEOC Hits Chicago Hospital With Bias Action
• Shire Targets Mylan In Latest Suit Over Generic Vyvanse
• Bills Target OTC Drug Restriction On Health Accounts
• Skadden Reps Valeant In $345M Jannsen Unit Buy
• Contemplating Pliva V. Mensing
• Walgreen To Pay $3M Over Mass. Overbilling Claims
• Hospital, Workers Must Address Union Status: 1st Circ.
• ITC To Probe Kaneka's Supplement Patent Claims
• Lupin Settles With Apotex Over Cholesterol Drug Patents
• EU IPR Customs Seizures Spiked In 2010: Report
• Using Financial Information In Settlement Negotiations
• Calif. Goes After Blue Shield To Cover Autism Therapy
• Teva Drops Azilect Patent Claim Against Watson, Mylan
• Rite Aid Sues Ranbaxy Over Reglan Suit Indemnity
• Novartis Sales Reps File Suit Over Unpaid OT
• Orchid Shareholder Drops Suit Over $85M LabCorp Deal
• US Has No Immunity In Prezista Patent Case: Judge
• FDA Proposes Guidelines For Targeted Drug Therapies
• Insurer Accuses Pitt Hospital Of Dirty Ad Campaign
• McDermott Nabs Ex-FTC Health Chief From Dechert
• 3 Plead Guilty In $200M Medicare Fraud Case
• Ex-Lawmaker Asks 9th Circ. To Revive PPACA Challenge
• Ill. Court Affirms $18M Verdict In Pain Patch Death
• Simpson Thacher Reps Apax In $6B Kinetic Concepts Deal
• FDA Warns Surgeons To Avoid Mesh Devices
• Boehringer Sales Rep Not Exempt From OT, Judge Says
• Dow, HP, Others Hit With Patent Suit Over HR Software
• Prometheus: Bound For Clarification Or Confusion?
• The Scope Of Questioning For A 30(b)(6) Deposition
• Quest Escapes FCA Suit Over Medicare Kickbacks
• Seattle Genetics Insider's Brother Pleads Guilty
• Biotronik Says CoStar Stent 'Recall' Violated Pact
• Astellas Settles Patent Suit Over Generic Adenoscan
• Winston Must Face Claims Over $56M Merger: Judge
• Fertility Insurer Accuses Rival Of Infringing Policies
• Braintree Ducks Indirect Purchasers' MiraLax Suit
• Edwards Angell Nabs MoFo IP Bigwig For NY Office
• Biomed Co. Loses Bid To Appeal Nixed Air Force Contract
• Translating India's New IT Law
• Extending Liability To Limited Partners In NJ
• Feds Say Scios Mislabeled Heart Drug Natrecor
• Takeda, Mylan Reach Agreement Over Prevacid Generic
• Title VII Caps Are Per Party, Not Per Claim: 5th Circ.
• Obama Directs Independent Agencies To Overhaul Rules
• Ex-Teva Scientist Testifies In Copaxone Patent Battle
• HHS Health Exchange Guidelines Provide Flexibility
• Perkins Coie Adds Patent Litigator in San Diego
• Medicare, Medicaid Sued Over Preferred Pharmacy Rule
• 8th Circ. Upholds Health Agency Officer's Firing
• Nev. Court Won't Boot PDL BioPharma, Genentech Row
• Alatech Fired Up Over Rejected Condoms
• Pfizer Targets Apotex In Fight To Block Generic Lyrica
• Jones Day Reps Sanofi In $425M Unit Sale To Valeant
• Purdue Targets Sandoz Over OxyContin Patents
• The Legal Duties Of Clinical Trial Sponsors
• Sandoz, Others Settle Medicaid Inflation MDL Suits
• Morgan Lewis Picks Up Jones Day Patent Pro
• Organon, Others Want $421M Medicaid FCA Suit Tossed
• Fed. Circ. Finds Respironics' Apnea Patents Invalid
• MarcTec Fights $5M Cordis Award In Fed. Circ.
• Fed. Circ. Overturns $5M RTI Win In Syringe IP Case
• Alleged Gangster Cops Plea In $100M Medicare Fraud Case
• Constitutionality Of Personal Health Insurance Mandate
• 4th Circ. Backs US In Medicaid Overbilling Row With W.Va.
• Watson Didn't Infringe Mucinex Patent: Fed. Circ.
• Teva Settles With Iowa In Wholesale Drug Suit
• MiraLax Plaintiffs Win Injunction Against Braintree
• Wyeth Illegally Blocked Effexor XR Generics: Suit
• Don't Rock The Concord Boat
• J&J Suppressed Sales Of Cancer Test: Suit
• Pfizer Dodges More Sanctions In Neurontin Antitrust MDL
• 11th Circ. Puts $195M Hospital Merger On Hold
• Inyx Shareholders Win Class Cert. In Fraud Battle
• Shire Targets Roxane, Watson Over Generic Vyvanse
• Ex-Troutman Sanders Atty Escapes Malpractice Suit
• DePuy, Calif. Co. Want Stryker Noncompete Deal Nixed
• FDA Bans Import Of Drugs From Dr. Reddy's Mexico Plant
• Protest Of $2B MetLife Military Dental Contract Nixed
• UK Court Favors Novartis In Lucentis Patent Suit
• Teva Asks Trial Judge To Dismiss Pfizer Viagra Suit
• Spotlight On Recent Preemption Decisions
• Boehringer Deal Leads EU Watchdog To Close Probe
• K&L Gates Adds Corporate Partners In Boston
• FDA Accuses Cadila Of Major Violations At India Plant
• Philips Defends Bonus Payouts In $172M Discus Deal
• EU Sees Drop In Pay-For-Delay Deals On Generics
• Universal Health Seeks Va. Docs In Medicaid FCA Suit
• Barr Must Produce Docs In Provigil Pay-For-Delay Suit
• Axiom Says Ex-Workers Stole Secrets, Trademarks
• FDA Slams Zoll Over Defibrillator Battery Life Issues
• St. Vincent's, Siemens Settle Contract Claim For $1.2M
• Hartford Off Hook For Nonprofit's $6.7M Madoff Losses
• CareFusion To Pay $150M For Drug Dispenser Co. Rowa
• Actavis Settles Sanofi Suit Over Generic Allegra
• Study Ties Pfizer Anti-Smoking Drug To Heart Problems
• Authenticating Electronic Evidence
• Ropes Reps TPG In $2B Bid To Take Immucor Private
• Shire Sues Sandoz, Amneal Over Vyvanse ANDA
• Ex-Stiefel Labs Exec Accuses Bosses Of $40M Con
• Mass. Hospital Enters Ch. 11 To Ease Sale
• Depakote May Cause Cognitive Defects, FDA Warns
• St. Vincent's Lands $34M Starting Bid For Nursing Unit
• Bard Offers $184M To Settle Hernia Patch Suits
• Dog Owners Denied Class Cert. In ProMeris Suit
• A Bitter Pill For Brand Names?